MBRX
Price
$0.84
Change
-$0.03 (-3.45%)
Updated
Apr 4, 02:39 PM (EDT)
Capitalization
11.56M
NTRB
Price
$5.58
Change
+$0.08 (+1.45%)
Updated
Apr 4, 02:18 PM (EDT)
Capitalization
64.08M
28 days until earnings call
Ad is loading...

MBRX vs NTRB

Header iconMBRX vs NTRB Comparison
Open Charts MBRX vs NTRBBanner chart's image
Moleculin Biotech
Price$0.84
Change-$0.03 (-3.45%)
Volume$600
Capitalization11.56M
Nutriband
Price$5.58
Change+$0.08 (+1.45%)
Volume$180
Capitalization64.08M
MBRX vs NTRB Comparison Chart
Loading...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBRX vs. NTRB commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBRX is a Hold and NTRB is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MBRX: $0.87 vs. NTRB: $5.50)
Brand notoriety: MBRX and NTRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBRX: 5% vs. NTRB: 9%
Market capitalization -- MBRX: $11.56M vs. NTRB: $64.08M
MBRX [@Biotechnology] is valued at $11.56M. NTRB’s [@Biotechnology] market capitalization is $64.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBRX’s FA Score shows that 0 FA rating(s) are green whileNTRB’s FA Score has 0 green FA rating(s).

  • MBRX’s FA Score: 0 green, 5 red.
  • NTRB’s FA Score: 0 green, 5 red.
According to our system of comparison, MBRX is a better buy in the long-term than NTRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBRX’s TA Score shows that 3 TA indicator(s) are bullish while NTRB’s TA Score has 4 bullish TA indicator(s).

  • MBRX’s TA Score: 3 bullish, 4 bearish.
  • NTRB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, MBRX is a better buy in the short-term than NTRB.

Price Growth

MBRX (@Biotechnology) experienced а -17.27% price change this week, while NTRB (@Biotechnology) price change was -16.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

MBRX is expected to report earnings on May 09, 2024.

NTRB is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRB($64.1M) has a higher market cap than MBRX($11.6M). NTRB YTD gains are higher at: 16.773 vs. MBRX (-48.900). NTRB has higher annual earnings (EBITDA): -6.52M vs. MBRX (-28.79M). MBRX has more cash in the bank: 9.41M vs. NTRB (5.7M). NTRB has less debt than MBRX: NTRB (200K) vs MBRX (506K). NTRB has higher revenues than MBRX: NTRB (2.02M) vs MBRX (0).
MBRXNTRBMBRX / NTRB
Capitalization11.6M64.1M18%
EBITDA-28.79M-6.52M441%
Gain YTD-48.90016.773-292%
P/E RatioN/AN/A-
Revenue02.02M-
Total Cash9.41M5.7M165%
Total Debt506K200K253%
FUNDAMENTALS RATINGS
MBRX vs NTRB: Fundamental Ratings
MBRX
NTRB
OUTLOOK RATING
1..100
8268
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9453
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBRX's Valuation (36) in the Pharmaceuticals Major industry is in the same range as NTRB (61) in the null industry. This means that MBRX’s stock grew similarly to NTRB’s over the last 12 months.

MBRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as NTRB (100) in the null industry. This means that MBRX’s stock grew similarly to NTRB’s over the last 12 months.

NTRB's SMR Rating (98) in the null industry is in the same range as MBRX (99) in the Pharmaceuticals Major industry. This means that NTRB’s stock grew similarly to MBRX’s over the last 12 months.

NTRB's Price Growth Rating (53) in the null industry is somewhat better than the same rating for MBRX (94) in the Pharmaceuticals Major industry. This means that NTRB’s stock grew somewhat faster than MBRX’s over the last 12 months.

NTRB's P/E Growth Rating (100) in the null industry is in the same range as MBRX (100) in the Pharmaceuticals Major industry. This means that NTRB’s stock grew similarly to MBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBRXNTRB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 24 days ago
75%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROIV10.01-0.07
-0.69%
Roivant Sciences Ltd
CABA1.19-0.05
-4.03%
Cabaletta Bio
AGX128.75-9.27
-6.72%
Argan
BHRB52.06-4.17
-7.42%
Burke & Herbert Financial Services Corp
CAT305.76-28.90
-8.64%
Caterpillar

MBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBRX has been loosely correlated with EDSA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MBRX jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBRX
1D Price
Change %
MBRX100%
-9.60%
EDSA - MBRX
36%
Loosely correlated
-5.31%
AMRN - MBRX
32%
Poorly correlated
-2.18%
DOMH - MBRX
30%
Poorly correlated
-9.95%
AXON - MBRX
29%
Poorly correlated
-3.35%
VKTX - MBRX
29%
Poorly correlated
-5.69%
More

NTRB and

Correlation & Price change

A.I.dvisor tells us that NTRB and VRAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTRB and VRAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
-4.68%
VRAX - NTRB
31%
Poorly correlated
-9.65%
NOXOF - NTRB
29%
Poorly correlated
N/A
SYRE - NTRB
27%
Poorly correlated
-9.68%
STOK - NTRB
27%
Poorly correlated
-4.55%
MBRX - NTRB
24%
Poorly correlated
-9.60%
More